1M
CRL icon

13D Management’s Charles River Laboratories CRL Stock Holding History

13D Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.85M Hold
25,800
– – 8.2% 6
2026
Q1 		$4.45M Sell
25,800
-2,200
-8% -$408K 6.9% 6
2025
Q4 		$5.59M Hold
28,000
– – 6.65% 6
2025
Q3 		$4.38M Hold
28,000
– – 4.2% 17
2025
Q2 		$4.25M Buy
+28,000
New +$3.73M 3.88% 14

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

13D Management's CRL Position: Q2 2026 in Review

13D Management held its Charles River Laboratories (CRL) position steady in Q2 2026 at 25,800 shares worth $5.85M. The position accounts for 8.2% of the portfolio, ranked #6.

13D Management first reported a position in CRL in Q2 2025 and has held it in 5 quarters since. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • 13D Management held 25,800 shares of Charles River Laboratories worth $5.85M as of Q2 2026.
  • 13D Management left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up 8.2% of 13D Management's portfolio in Q2 2026, its #6 holding.
  • 13D Management first reported a position in Charles River Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on 13D Management's 13F filing for Q2 2026, filed 14 Aug 2026.